close

Fenwick Represents Natus Medical in $18.6 Million Acquisition of Grass Technologies Product Group from Astro-Med

January 07, 2013

​Fenwick & West represented Natus Medical (NASDAQ:BABY), a provider of medical products for newborn care, in its acquisition of the Grass Technologies Product Group from Astro-Med. The Grass Technologies Product Group includes clinically differentiated neurodiagnostic and monitoring products, including a portfolio of polysomnography (PSG) and electroencephalography (EEG) systems for both clinical and research use and related accessories and proprietary electrodes. Astro-Med will retain its Grass manufacturing facility and the companies have entered into an agreement whereby Astro-Med will continue to manufacture the Grass products and provide other transition services for a period of time, after which Natus will acquire any remaining inventory. The transaction is expected to close on January 31. Natus will fund the approximate $18.6 million cash purchase price with existing cash and borrowings under its credit facility.

The Fenwick transaction team included corporate attorneys Dan Winnike, Gaurav Sud and Allison Cooper, technology transactions attorney Stefano Quintini and executive compensation and employee benefits attorney Blake Martell.